AYALA PHARMACEUTICALS, INC.

Profile

Company Names

AYALA PHARMACEUTICALS, INC.
ADVAXIS, INC.

Addresses

9 DEER PARK DRIVE, SUITE K-1, MONMOUTH JUNCTION, NJ 08852

9 DEER PARK DRIVE, SUITE K-1, MONMOUTH JUNCTION, NJ 08852

305 COLLEGE ROAD EAST, PRINCETON, NJ 08540

TECHNOLOGY CENTRE OF NEW JERSEY, 675 ROUTE 1, NORTH BRUNSWICK, NJ 08902

Phone Numbers

732 545 1590
732-545-1590
609-452-9813

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$44,853,919.00

Number of Funding Rounds:

14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2023-10-18 
$433,825.00 
$433,825.00 
$0.00 
Equity 
13
2022-01-31 
$4,750,000.00 
$4,750,000.00 
$0.00 
Equity 
12
2021-04-14 
$11,093,521.00 
$11,093,521.00 
$0.00 
 
11
2012-11-13 
$0.00 
$10,000,000.00 
$10,000,000.00 
Equity 
10
2012-05-18 
$715,000.00 
INDEFINITE 
INDEFINITE 
Debt 
9
2012-05-14 
$4,473,673.00 
INDEFINITE 
INDEFINITE 
Equity 
8
2012-01-09 
$1,047,500.00 
INDEFINITE 
INDEFINITE 
Debt 
7
2011-10-31 
$1,977,500.00 
INDEFINITE 
INDEFINITE 
Debt 
6
2011-05-12 
$6,016,250.00 
INDEFINITE 
INDEFINITE 
Debt 
5
2010-11-01 
$835,000.00 
INDEFINITE 
INDEFINITE 
Debt 
4
2010-07-19 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
3
2009-10-07 
$50,000.00 
INDEFINITE 
INDEFINITE 
Debt 
2
2009-09-24 
$5,000,000.00 
$5,000,000.00 
$0.00 
 
1
2009-06-17 
$961,650.00 
INDEFINITE 
INDEFINITE 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RONI 
 
APPEL 
DIRECTOR
RONI 
A. 
APPEL 
DIRECTOR
KEN 
A. 
BERLIN 
DIRECTOR, EXECUTIVE OFFICER
KENNETH 
 
BERLIN 
EXECUTIVE OFFICER, DIRECTOR
VERED 
 
BISKER-LEIB 
DIRECTOR
YUVAL 
 
CABILLY 
DIRECTOR
FREDRICK 
 
COBB 
EXECUTIVE OFFICER
IGOR 
 
GITELMAN 
EXECUTIVE OFFICER, DIRECTOR
ROY 
 
GOLAN 
EXECUTIVE OFFICER
MURRAY 
A. 
GOLDBERG 
DIRECTOR
ANDRES 
 
GUTIERREZ 
EXECUTIVE OFFICER
SAMIR 
 
KHLEIF 
DIRECTOR
THOMAS 
 
MCKEARN 
DIRECTOR
THOMAS 
L. 
MCKEARN 
DIRECTOR
THOMAS 
 
MOORE 
DIRECTOR, EXECUTIVE OFFICER
THOMAS 
A. 
MOORE 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
PATTON 
DIRECTOR
MARK 
J. 
ROSENBLUM 
EXECUTIVE OFFICER
JOHN 
 
ROTHMAN 
EXECUTIVE OFFICER
JOHN 
M. 
ROTHMAN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-10-18 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
Equity 
2022-01-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$1,000,001 - $5,000,000 
 
2021-04-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-11-13 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2012-05-18 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-05-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2012-01-09 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-10-31 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2011-05-12 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-11-01 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-07-19 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-10-07 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2009-09-24 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-06-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
NONE
NONE
RODMAN + RENSHAW, LLC
NONE
NONE
RODMAN + RENSHAW, LLC
LAIDLAW + COMPANY (UK) LTD.
MATTHEW D. EITNER
NONE
NONE
EVAN GREENBERG
NONE
NONE
NONE
EVAN GREENBERG
NONE
CARTER SECURITIES, LLC
JOHN CARTER LIPMAN